Medicare hangs a pretty small carrot for P4P, as Dr. Wes explains:
The implication of this bribery for reporting is significant, since it establishes a measly 1.5% premium on “Pay for Performance” – hardly a robust incentive. For instance, for a 20-minute outpatient follow-up visit that averages a $54 dollar Medicare reimbursement, Medicare is willing to pay an additional $0.81 for us to submit data about the drugs we give the patient. Since the payment isn’t enough to offset the cost in man-hours to supply the data, will the data be complete or accurate?
Related posts:
- Medicare and denying access to drugs
- Are patients the real "drug pushers?"
- Medicare covers more cancer drugs, did they cave in to the pharmaceutical lobby?
- The real Medicare myth
- Vytorin, the "besmirched drug du jour"
- The make-believe savings of single-payer
- EHRs in the real world
KevinMD.com on Facebook
{ 1 comment }
Why don’t p4p people get it. For me to do p4p, I need a ral incentive. Either put me in jail for not reporting # of times I did a1c’s on Joe Doe or give me what I deserve when I take care of patients on a chronic care level. p4p is penny wise, pound foolish. Do people know that in England, GPs had an incrase income nearl 50% by following p4p guidelines!!!
Comments on this entry are closed.